Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/14798
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Neyt, Mattias | - |
dc.contributor.author | CLEEMPUT, Irina | - |
dc.contributor.author | Thiry, Nancy | - |
dc.contributor.author | De Laet, Chris | - |
dc.date.accessioned | 2013-03-22T16:22:04Z | - |
dc.date.available | 2013-03-22T16:22:04Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | HEALTH POLICY, 106 (2), p. 207-210 | - |
dc.identifier.issn | 0168-8510 | - |
dc.identifier.uri | http://hdl.handle.net/1942/14798 | - |
dc.description.abstract | Economic evaluations most often use results from randomised controlled trials (RCTs) to model effectiveness. Inconsiderate application of the absolute treatment effect from RCTs may result in unrealistic estimates of an intervention's benefit for the real-world target population. The baseline risk of events in this target population may differ significantly from the baseline risk in the RCT population. An approach to handle this problem is to combine observational data with evidence from RCTs. Reliable administrative or register data can provide an estimate of the real-world baseline risks. In combination with the relative treatment effect from well-performed RCTs this results in an estimate of the absolute benefit for the relevant target population. Applying this approach, one must remain cautious about the validity of the assumption of a constant relative treatment effect. (C) 2012 Elsevier Ireland Ltd. All rights reserved. | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.subject.other | Health Care Sciences & Services; Health Policy & Services; methodology; cost-benefit analysis; effectiveness; randomized controlled trial; observational data | - |
dc.subject.other | Methodology; Cost-benefit analysis; Effectiveness; Randomised controlled trial; Observational data | - |
dc.title | Calculating an intervention's (cost-)effectiveness for the real-world target population: The potential of combining strengths of both RCTs and observational data | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 210 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 207 | - |
dc.identifier.volume | 106 | - |
local.format.pages | 4 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Neyt, Mattias; Cleemput, Irina; Thiry, Nancy; De Laet, Chris] Belgian Hlth Care Knowledge Ctr KCE, Brussels, Belgium. | - |
local.publisher.place | CLARE | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1016/j.healthpol.2012.04.014 | - |
dc.identifier.isi | 000305671300013 | - |
item.fullcitation | Neyt, Mattias; CLEEMPUT, Irina; Thiry, Nancy & De Laet, Chris (2012) Calculating an intervention's (cost-)effectiveness for the real-world target population: The potential of combining strengths of both RCTs and observational data. In: HEALTH POLICY, 106 (2), p. 207-210. | - |
item.contributor | Neyt, Mattias | - |
item.contributor | CLEEMPUT, Irina | - |
item.contributor | Thiry, Nancy | - |
item.contributor | De Laet, Chris | - |
item.accessRights | Closed Access | - |
item.fulltext | No Fulltext | - |
crisitem.journal.issn | 0168-8510 | - |
crisitem.journal.eissn | 1872-6054 | - |
Appears in Collections: | Research publications |
SCOPUSTM
Citations
4
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
4
checked on Sep 26, 2024
Page view(s)
110
checked on Jun 14, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.